Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F T Cutts

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
AIDS (London, England)|March 28, 1998
Age- and sex-specific HIV-1 prevalence in the urban community setting of Addis Ababa, EthiopiaA L Fontanet, T Messele, A Dejene, et al.
Vaccine|December 3, 2019
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applicationsF T Cutts, E Dansereau, M J Ferrari, et al.
Vaccine|June 3, 2008
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The GambiaM Saaka, B J Okoko, R C Kohberger, et al.
Lancet (London, England)|March 30, 2005
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialF T Cutts, S M A Zaman, G Enwere, et al.
Vaccine|December 8, 2022
Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20C Prosperi, J W V Thangaraj, A Z Hasan, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
AIDS (London, England)|March 28, 1998
Age- and sex-specific HIV-1 prevalence in the urban community setting of Addis Ababa, EthiopiaA L Fontanet, T Messele, A Dejene, et al.
Vaccine|December 3, 2019
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applicationsF T Cutts, E Dansereau, M J Ferrari, et al.
Vaccine|June 3, 2008
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The GambiaM Saaka, B J Okoko, R C Kohberger, et al.
Lancet (London, England)|March 30, 2005
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialF T Cutts, S M A Zaman, G Enwere, et al.
Vaccine|December 8, 2022
Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20C Prosperi, J W V Thangaraj, A Z Hasan, et al.
Pageof 8